Market Cap | 23.20M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.29M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -8.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -33.00% |
Dividend | N/A | Price/Book | 3.15 | EPS next 5Y | - | 52W High Chg | -64.00% |
Recommedations | - | Quick Ratio | 47.30 | Shares Outstanding | 114.14M | 52W Low Chg | 12.00% |
Insider Own | 8.62% | ROA | -22.95% | Shares Float | 104.55M | Beta | 2.26 |
Inst Own | 0.01% | ROE | -36.85% | Shares Shorted/Prior | -/- | Price | 0.20 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 43,425 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 55,345 | Change | -0.33% |
Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath analyzers, a point of care breath testing tool for the rapid detection of recent cannabis use; MS breath sampler; and contactless alcohol breathalyzer, as well as breath collection units. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.